Generics - Sanofi, Pharmaceutical


Current filters:


Popular Filters

US FDA warns pregnant women to not use valproate migraine prevention medicines


The US Food and Drug Administration is alerting health care providers and patients that medications including…

Abbott LaboratoriesGenericsNeurologicalNorth AmericaNoven PharmaceuticalsPharmaceuticalRegulationSanofivalproate Sodium Injection

Court rules in novel False Claims Act case where one pharma firm sues another viewed by HP&M lawyer


The US District Court for the Central District of California issued a ruling recently in an unusual,…

AmphastarGenericsLegalLovenoxNorth AmericaPharmaceuticalPricingSanofi

Sanofi yet another to be hit by generic competition


Continuing the trend reported by other drug majors reporting third-quarter 2012 financial results so…


Pharma vs the world: Big Pharma caught between investors and public


Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient…

FinancialGenericsGlobalMarkets & MarketingPatentsPharmaceuticalPoliticsSanofi

Bristol-Myers anticipates significant decline in US clopidogrel sales as patent lapses


GenericsWeb, a patent analysis and search company, recently published an article based on its proprietary…

Bristol-Myers SquibbCardio-vascularClopidogrelGenericsPatentsPharmaceuticalPlavixSanofi

Sanofi and Bayer consider Russian expansion, product launches


Two European drug majors - France-based Sanofi (Euronext: SAN) and German company Bayer (BAY: DE) have…

BayerEuropeGenericsInsulinMarkets & MarketingPharmaceuticalSanofi

Sanofi considers expanding in Ukraine pharma market


French drug major Sanofi (Euronext: SAN) is considering a massive expansion into the Ukrainian pharmaceutical…

EuropeGenericsMarkets & MarketingPharmaceuticalSanofi

Back to top